Metropolitan Life Insurance Company (MetLife)’s Advantage Solutions ADV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-202
Closed -$21.8K 54
2024
Q1
$21.8K Hold
202
﹤0.01% 1813
2023
Q4
$18.3K Hold
202
﹤0.01% 1956
2023
Q3
$14.3K Hold
202
﹤0.01% 2048
2023
Q2
$11.8K Buy
202
+135
+201% +$5.78K ﹤0.01% 2216
2023
Q1
$2.63K Sell
67
-163
-71% -$9.2K ﹤0.01% 2295
2022
Q4
$12K Buy
230
+8
+4% +$503 ﹤0.01% 2227
2022
Q3
$11.8K Hold
222
﹤0.01% 2258
2022
Q2
$21.1K Hold
222
﹤0.01% 2030
2022
Q1
$35.4K Sell
222
-720
-76% -$125K ﹤0.01% 1788
2021
Q4
$189K Hold
942
﹤0.01% 2069
2021
Q3
$204K Hold
942
﹤0.01% 2054
2021
Q2
$254K Buy
+942
New +$291K ﹤0.01% 1978

Other funds holding ADV

Metropolitan Life Insurance Company (MetLife)'s ADV Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Advantage Solutions (ADV) in Q2 2024, closing a stake of 202 shares — an estimated $21.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ADV in Q2 2021 and held it in 12 quarters. The position peaked at $254K in Q2 2021. 119 funds tracked by Wall St. Rank hold ADV as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Advantage Solutions position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 202 Advantage Solutions shares in Q2 2024, an estimated $21.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Advantage Solutions in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Advantage Solutions position peaked at $254K in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Advantage Solutions as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.